Searched for: Department/Unit:Otolaryngology
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer
Brand, Toni M; Hartmann, Stefan; Bhola, Neil E; Li, Hua; Zeng, Yan; O'Keefe, Rachel A; Ranall, Max V; Bandyopadhyay, Sourav; Soucheray, Margaret; Krogan, Nevan J; Kemp, Carolyn; Duvvuri, Umamaheswar; LaVallee, Theresa; Johnson, Daniel E; Ozbun, Michelle A; Bauman, Julie E; Grandis, Jennifer R
PMID: 36052496
ISSN: 1538-7445
CID: 5482442
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers
Brody, Robert M; Shimunov, David; Cohen, Roger B; Lin, Alexander; Lukens, John N; Hartner, Lee; Aggarwal, Charu; Duvvuri, Umamaheswar; Montone, Kathleen T; Jalaly, Jalal B; LiVolsi, Virginia A; Carey, Ryan M; Shanti, Rabie M; Rajasekaran, Karthik; Chalian, Ara A; Rassekh, Christopher H; Cannady, Steven B; Newman, Jason G; O'Malley, Bert W; Weinstein, Gregory S; Gimotty, Phyllis A; Basu, Devraj
OBJECTIVES:Increasing use of transoral robotic surgery (TORS) is likely to impact outcomes for HPV+ oropharyngeal squamous cell carcinomas (OPSCCs). We aimed to describe oncologic outcomes for a large HPV+ OPSCC cohort after TORS and develop a risk prediction model for recurrence under this treatment paradigm. MATERIALS AND METHODS:634 HPV+ OPSCC patients receiving TORS-based therapy at a single institution were reviewed retrospectively to describe survival across the entire cohort and for patients suffering recurrence. Risks for distant metastatic recurrence (DMR) and locoregional recurrence (LRR) were modeled using multivariate logistic regression analyses of case-control sub-cohorts. RESULTS:5-year overall and recurrence-free survival were 91.2% and 86.1%, respectively. 5-year overall survival was 52.5% following DMR and 83.3% after isolated LRR (P = .01). In case-control analyses, positive surgical margins were associated with DMR (adjusted OR 5.8, CI 2.1-16.0, P = .001), but not isolated LRR, and increased DMR risk 4.2 fold in patients with early clinical stage disease. By contrast, LRR was associated with not receiving recommended adjuvant therapy (OR 13.4, CI 6.3-28.5, P < .001). CONCLUSIONS:This study sets a benchmark for oncologic outcomes from HPV+ OPSCC after TORS-based therapy. Under this treatment paradigm, margins are relevant for assessing lethal recurrence risk during clinical trial design and post-treatment surveillance.
PMCID:9288202
PMID: 35245888
ISSN: 1879-0593
CID: 5482382
Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy
Vyas, Avani; Gomez-Casal, Roberto; Cruz-Rangel, Silvia; Villanueva, Hugo; Sikora, Andrew G; Rajagopalan, Pavithra; Basu, Devraj; Pacheco, Jonathan; Hammond, Gerald R V; Kiselyov, Kirill; Duvvuri, Umamaheswar
Squamous cell carcinoma of the head and neck (SCCHN) is a devastating disease that continues to have low cure rates despite the recent advances in therapies. Cisplatin is the most used chemotherapy agent, and treatment failure is largely driven by resistance to this drug. Amplification of chromosomal band 11q13 occurs in ∼30% of SCCHN tumors. This region harbors the ANO1 gene that encodes the TMEM16A ion channel, which is responsible for calcium-activated chloride transport in epithelial tissues. TMEM16A overexpression is associated with cisplatin resistance, and high TMEM16A levels correlate with decreased survival. However, the mechanistic underpinning of this effect remains unknown. Lysosomal biogenesis and exocytosis have been implicated in cancer because of their roles in the clearance of damaged organelles and exocytosis of chemotherapeutic drugs and toxins. Here, we show that TMEM16A overexpression promotes lysosomal biogenesis and exocytosis, which is consistent with the expulsion of intracellular cisplatin. Using a combination of genetic and pharmacologic approaches, we find that TMEM16A promotes lysosomal flux in a manner that requires reactive oxygen species, TRPML1, and the activation of the β-catenin–melanocyte-inducing transcription factor pathway. The lysosomal inhibitor hydroxychloroquine (HCQ) synergizes with cisplatin in killing SCCHN cells in vitro. Using a murine model of SCCHN, we show that HCQ and cisplatin retard the growth of cisplatin-resistant patient-derived xenografts in vivo. We propose that TMEM16A enables cell survival by the up-regulation of lysosomal sequestration and exocytosis of the cytotoxic drugs. These results uncover a model of treatment for resistance in cancer, its reversal, and a role for TMEM16A.
PMCID:8944912
PMID: 35286200
ISSN: 1091-6490
CID: 5482392
Assessing the learning curve associated with a novel flexible robot in the pre-clinical and clinical setting
Zhu, Toby S; Godse, Neal; Clayburgh, Daniel R; Duvvuri, Umamaheswar
BACKGROUND:Transoral robotic surgery has been successfully used by head and neck surgeons for a variety of procedures but is limited by rigid instrumentation and line-of-sight visualization. Non-linear systems specifically designed for the aerodigestive tract are needed. Ease of use of these new systems in both training and clinical environments is critical in its widespread adoption. METHODS:Residents, fellows, and junior faculty performed four tasks on an anatomical airway mannequin using the Medrobotics FLEX™ Robotic System: expose and incise the tonsil, grasp the epiglottis, palpate the vocal processes, and grasp the interarytenoid space. These tasks were performed once a day for four days; after a 4-month time gap, subjects were asked to perform these same tasks for three more days. Time to task completion and total distance driven were tracked. In addition, a retrospective analysis was performed analyzing one attending physician's experience with clinical usage of the robot. RESULTS:13 subjects completed the initial round of the mannequin simulation and 8 subjects completed the additional testing 4 months later. Subjects rapidly improved their speed and efficiency at task completion. Junior residents were slower in most tasks initially compared to senior trainees but quickly reached similar levels of efficiency. Following the break there was minimal degradation in skills and continued improvement in efficiency was observed with additional trials. There was significant heterogeneity in the analyzed clinical cases, but when analyzing cases of similar complexity and pathology, clear decreases in overall operative times were demonstrable. CONCLUSION:Novice users quickly gained proficiency with the FLEX™ Robotic System in a training environment, and these skills are retained after several months. This learning could translate to the clinical setting if a proper training regimen is developed. The Medrobotics FLEX™ Robotic System shows promise as a surgical tool in head and neck surgery in this study.
PMCID:8733873
PMID: 33751213
ISSN: 1432-2218
CID: 5482212
Essential Cases in Head and Neck Oncology
Moore, Michael G.; Bewley, Arnaud F.; Givi, Babak
[S.l.] : wiley, 2022
Extent: 1 v.
ISBN: 9781119775942
CID: 5460962
Oral Cavity
Chapter by: Heaton, Chase; Givi, Babak; Moore, Michael G.; Pathak, Alok; Bewley, Arnaud F.; Ganly, Ian
in: Essential Cases in Head and Neck Oncology by
[S.l.] : wiley, 2022
pp. 1-19
ISBN: 9781119775942
CID: 5460952
Fanconi anemia pathway deficiency drives copy number variation in squamous cell carcinoma. [Meeting Abstract]
Webster, Andrew L.; Sanders, Mathijs A.; Patel, Krupa; Dietrich, Ralf; Noonan, Raymond J.; Lach, Francis P.; White, Ryan R.; Goldfarb, Audrey M.; Hadi, Kevin; Edwards, Matthew M.; Donovan, Frank X.; Jung, Moonjung; Sridhar, Sunandini; Fedrigo, Olivier; Tian, Huasong; Rosiene, Joel; Heineman, Thomas; Kennedy, Jennifer; Bean, Lorenzo; Rosti, Rasim O.; Tryon, Rebecca; Gonzalez, Ashlyn-Maree; Rosenberg, Allana; Luo, Ji-Dung; Carrol, Thomas; Velleuer, Eunike; Rastatter, Jeff C.; Wells, Susanne I.; Surralles, Jordi; Bagby, Grover; MacMillan, Margaret L.; Wagner, John E.; Cancio, Maria; Boulad, Farid; Scognamiglio, Theresa; Vaughan, Roger; Koren, Amnon; Imielinski, Marcin; Chandrasekharappa, Settara; Auerbach, Arleen D.; Singh, Bhuvanesh; Kutler, David; Campbell, Peter J.; Smogorzewska, Agata
ISI:000892509501255
ISSN: 0008-5472
CID: 5459432
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer
Webster, Andrew L H; Sanders, Mathijs A; Patel, Krupa; Dietrich, Ralf; Noonan, Raymond J; Lach, Francis P; White, Ryan R; Goldfarb, Audrey; Hadi, Kevin; Edwards, Matthew M; Donovan, Frank X; Hoogenboezem, Remco M; Jung, Moonjung; Sridhar, Sunandini; Wiley, Tom F; Fedrigo, Olivier; Tian, Huasong; Rosiene, Joel; Heineman, Thomas; Kennedy, Jennifer A; Bean, Lorenzo; Rosti, Rasim O; Tryon, Rebecca; Gonzalez, Ashlyn-Maree; Rosenberg, Allana; Luo, Ji-Dung; Carroll, Thomas S; Shroff, Sanjana; Beaumont, Michael; Velleuer, Eunike; Rastatter, Jeff C; Wells, Susanne I; Surrallés, Jordi; Bagby, Grover; MacMillan, Margaret L; Wagner, John E; Cancio, Maria; Boulad, Farid; Scognamiglio, Theresa; Vaughan, Roger; Beaumont, Kristin G; Koren, Amnon; Imielinski, Marcin; Chandrasekharappa, Settara C; Auerbach, Arleen D; Singh, Bhuvanesh; Kutler, David I; Campbell, Peter J; Smogorzewska, Agata
Fanconi anaemia (FA), a model syndrome of genome instability, is caused by a deficiency in DNA interstrand crosslink repair resulting in chromosome breakage1-3. The FA repair pathway protects against endogenous and exogenous carcinogenic aldehydes4-7. Individuals with FA are hundreds to thousands fold more likely to develop head and neck (HNSCC), oesophageal and anogenital squamous cell carcinomas8 (SCCs). Molecular studies of SCCs from individuals with FA (FA SCCs) are limited, and it is unclear how FA SCCs relate to sporadic HNSCCs primarily driven by tobacco and alcohol exposure or infection with human papillomavirus9 (HPV). Here, by sequencing genomes and exomes of FA SCCs, we demonstrate that the primary genomic signature of FA repair deficiency is the presence of high numbers of structural variants. Structural variants are enriched for small deletions, unbalanced translocations and fold-back inversions, and are often connected, thereby forming complex rearrangements. They arise in the context of TP53 loss, but not in the context of HPV infection, and lead to somatic copy-number alterations of HNSCC driver genes. We further show that FA pathway deficiency may lead to epithelial-to-mesenchymal transition and enhanced keratinocyte-intrinsic inflammatory signalling, which would contribute to the aggressive nature of FA SCCs. We propose that the genomic instability in sporadic HPV-negative HNSCC may arise as a result of the FA repair pathway being overwhelmed by DNA interstrand crosslink damage caused by alcohol and tobacco-derived aldehydes, making FA SCC a powerful model to study tumorigenesis resulting from DNA-crosslinking damage.
PMID: 36450981
ISSN: 1476-4687
CID: 5459302
Circulating Tumor HPV-DNA Kinetics in p16+Oropharyngeal Cancer Patients Undergoing Adaptive Radiation De-Escalation Based on Mid-Treatment Nodal Response [Meeting Abstract]
Kim, J. K.; Tam, M.; Oh, C.; Feron-Rigodon, M.; Joseph, B.; Vaezi, A. E.; Li, Z.; Tran, T.; Kim, G.; Zan, E.; Corby, P.; Fitz, C. Del Vecchio; Goldberg, J. D.; Hochman, T.; Givi, B.; Jacobson, A.; Persky, M.; Persky, M.; Hu, K. S.
ISI:000892639301045
ISSN: 0360-3016
CID: 5439722
Linking molecular abnormalities to balance deficits using a zebrafish model for tauopathies
Zhu, Yunlu; Leary, Paige; Bai, Qing; Burton, Edward A.; Schoppik, David
Background: The ability to maintain balance is an evolutionarily-conserved behavior that is frequently disrupted found in patients with neurodegenerative diseases. One of the most prominent balance disorders is found in patients with progressive supranuclear palsy (PSP), a primary tauopathy pathologically characterized by tau over-representation in the brainstem vestibulospinal (VS) nucleus, where they frequently exhibit accidental-backward falls starting from the early stage of the disease. Although pathological features of PSP correlate well with its clinical phenotype, how tau aggregation affects neuronal and circuit functions, which eventually leads to behavioral deficits, remains unclear. Method: To dissect disease mechanisms across molecular, cellular, circuitry, and behavioral levels, we generated tau fish by expressing human 0N/4R-Tau in zebrafish VS nucleus. Tau expression and phosphorylation were validated using immunohistochemistry staining with PHF-1 antibody. To examine the effect of tau on balance behavior, we measured postural control of free-swimming tau fish and compared to that of tau-negative siblings. Moreover, we tested response of VS neurons to nose-down and nose-up tilt stimulus using 2-photon calcium imaging. Result: Ttau-expressing zebrafish exhibit impaired balance control while maintaining normal locomotor ability. Interestingly, we did not observe any neuronal death in the VS nucleus. Functional imaging of the VS nucleus shows impaired directional tuning in tau-expressing neurons in response to tilt stimulus. We also found ectopic accumulation of acidic organelles in the cell bodies of tau-positive neurons, suggesting abnormal lysosomal function. Conclusion: Our results demonstrate how molecular abnormalities disrupt specific behavior in tauopathies before neurodegeneration appeared.
SCOPUS:85144463788
ISSN: 1552-5260
CID: 5393922